Author:
Lombardino Joseph G.,Lowe John A.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference30 articles.
1. R&D execs paint bleak picture of industry productivity: $1.4 bil. per NME. The Pink Sheet 6 (18 August 2003).
2. Demesmaeker, M. in Proc. 13th European Symp. Quantitative Structure-Activity Relationships: Rational Approaches to Drug Design (eds Hoeltje, H.-D. & Sippl, W.) 506–511 (Prous Science, Barcelona, 2000).
3. Chanda, S. K. & Caldwell, J. S. Fulfilling the promise: drug discovery in the post-genomic era. Drug Discov. Today 8, 168–174 (2003).
4. Reich, S. H. & Webber, S. E. Structure-based drug design (SBDD): every structure tells a story. Perspect. Drug Discov. Design 1, 371–390 (1993).
5. Lin, J. H. & Yamazaki, M. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin. Pharmacokinet. 42, 59–98 (2003).
Cited by
285 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献